• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌筛查与治疗的新建议。

New recommendations in prostate cancer screening and treatment.

作者信息

Adams Lisa K, Ferrington Lindsay S

机构信息

Lisa K. Adams practices hematology/oncology at Feist-Weiller Cancer Center in Shreveport, La., and is a recent graduate of the PA program at Louisiana State University's Health Sciences Center in Shreveport, La. Lindsay S. Ferrington is an instructor in the Louisiana State University PA program. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2014 Aug;27(8):14-20; quiz 26. doi: 10.1097/01.JAA.0000451872.86566.bf.

DOI:10.1097/01.JAA.0000451872.86566.bf
PMID:24988136
Abstract

Prostate cancer is the most commonly diagnosed nonskin cancer in men, with 233,000 new cases estimated for 2014. Nearly 30,000 deaths are predicted for 2014, second only to lung and bronchial cancer deaths. Early diagnosis is key to improving patient survival rates. Screening efforts have dramatically increased the detection rate, and now, 90% of new diagnoses are caught at the early stage of disease. However, new data are driving controversial changes to screening and treatment recommendations.

摘要

前列腺癌是男性中最常被诊断出的非皮肤癌,预计2014年有23.3万新病例。预计2014年将有近3万人死亡,仅次于肺癌和支气管癌的死亡人数。早期诊断是提高患者生存率的关键。筛查工作显著提高了检出率,现在,90%的新诊断病例是在疾病早期发现的。然而,新数据正在推动对筛查和治疗建议产生有争议的变化。

相似文献

1
New recommendations in prostate cancer screening and treatment.前列腺癌筛查与治疗的新建议。
JAAPA. 2014 Aug;27(8):14-20; quiz 26. doi: 10.1097/01.JAA.0000451872.86566.bf.
2
Prostate cancer screening: what's a fellow to do?前列腺癌筛查:该怎么做呢?
S D Med. 2010;Spec No:41-5.
3
Prostate-specific antigen screening for prostate cancer in older men in the United States of America.美国老年男性前列腺癌的前列腺特异性抗原筛查。
Gerontology. 2012;58(4):331-6. doi: 10.1159/000334242. Epub 2012 Feb 16.
4
Screening for prostate cancer: the current evidence and guidelines controversy.前列腺癌筛查:当前证据与指南争议
Can J Urol. 2011 Oct;18(5):5875-83.
5
Screening for prostate cancer remains controversial.前列腺癌筛查仍然存在争议。
BMJ. 2009 Sep 24;339:b3601. doi: 10.1136/bmj.b3601.
6
CE: early localized prostate cancer.CE:早期局限性前列腺癌。
Am J Nurs. 2015 Mar;115(3):34-44; quiz 45-6. doi: 10.1097/01.NAJ.0000461809.26978.cd.
7
Prostate-specific antigen screening, why have the guidelines changed?前列腺特异性抗原筛查,为何指南发生了变化?
Expert Rev Anticancer Ther. 2014 Nov;14(11):1277-81. doi: 10.1586/14737140.2014.971111. Epub 2014 Oct 13.
8
Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.患者摘要。前列腺癌筛查:美国医师协会临床指南委员会的一份指导声明。
Ann Intern Med. 2013 May 21;158(10):I-28. doi: 10.7326/0003-4819-158-10-201305210-00634.
9
Urologists' personal feelings on PSA screening and prostate cancer treatment.泌尿科医生对前列腺特异性抗原(PSA)筛查和前列腺癌治疗的个人看法。
J Eval Clin Pract. 2014 Aug;20(4):408-10. doi: 10.1111/jep.12149. Epub 2014 May 5.
10
Prostate cancer screening.前列腺癌筛查。
Prim Care. 2014 Jun;41(2):355-70. doi: 10.1016/j.pop.2014.02.009. Epub 2014 Mar 26.

引用本文的文献

1
FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer.FAM46C 通过 PTEN/AKT 信号通路抑制细胞增殖和细胞周期进程,促进细胞凋亡,并与前列腺癌的化疗敏感性相关。
Aging (Albany NY). 2020 Apr 13;12(7):6352-6369. doi: 10.18632/aging.103030.
2
Do African-American men need separate prostate cancer screening guidelines?非裔美国男性是否需要单独的前列腺癌筛查指南?
BMC Urol. 2016 May 10;16(1):19. doi: 10.1186/s12894-016-0137-7.